Select Page
Alzheimer’s disease

Alzheimer’s disease

Alzheimer disease, AD Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the presence in the central nervous system of extracellular amyloid beta (Aβ) plaques, intracellular neurofibrillary tangles, translating into memory defects...
NanoSIRNA

NanoSIRNA

NanosiRNA® COVID-19: specific antiviral treatment Medesis Pharma has a microemulsion technology that enables it to deliver these non-modified native siRNAs directly into the cytoplasm of all the organism’s cells via the HDL lipoprotein receptors, crossing the...
NanoManganese

NanoManganese

Medesis Pharma is developing a radioprotection drug to treat people irradiated following a civil or military nuclear accident (NP02 – NanoManganese®). Preclinical trials have been carried out with the French Armed Forces Biomedical Research Institute (IRBA)....
Transgene

Transgene

TRANSGENE (Euronext Paris: TNG), a biotechnology company designing and developing virus-based immunotherapies against cancers and infectious diseases, has signed a collaborative research agreement with Medesis Pharma with exclusive license options to co-develop an...